A detailed history of Riverbridge Partners LLC transactions in Haleon PLC stock. As of the latest transaction made, Riverbridge Partners LLC holds 21,991 shares of HLN stock, worth $213,972. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,991
Previous 21,991 -0.0%
Holding current value
$213,972
Previous $181,000 28.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$8.01 - $8.64 $30,950 - $33,384
3,864 Added 21.32%
21,991 $181,000
Q4 2023

Jan 24, 2024

BUY
$7.78 - $8.62 $141,028 - $156,254
18,127 New
18,127 $149,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.9B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Riverbridge Partners LLC Portfolio

Follow Riverbridge Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.